311 related articles for article (PubMed ID: 16987014)
1. NADPH oxidases in the kidney.
Gill PS; Wilcox CS
Antioxid Redox Signal; 2006; 8(9-10):1597-607. PubMed ID: 16987014
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
[TBL] [Abstract][Full Text] [Related]
3. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.
Dechend R; Viedt C; Müller DN; Ugele B; Brandes RP; Wallukat G; Park JK; Janke J; Barta P; Theuer J; Fiebeler A; Homuth V; Dietz R; Haller H; Kreuzer J; Luft FC
Circulation; 2003 Apr; 107(12):1632-9. PubMed ID: 12668498
[TBL] [Abstract][Full Text] [Related]
4. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices.
Reinehr R; Görg B; Becker S; Qvartskhava N; Bidmon HJ; Selbach O; Haas HL; Schliess F; Häussinger D
Glia; 2007 May; 55(7):758-71. PubMed ID: 17352382
[TBL] [Abstract][Full Text] [Related]
5. Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression.
Xia L; Wang H; Goldberg HJ; Munk S; Fantus IG; Whiteside CI
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F345-56. PubMed ID: 16131649
[TBL] [Abstract][Full Text] [Related]
6. Suppressing renal NADPH oxidase to treat diabetic nephropathy.
Tojo A; Asaba K; Onozato ML
Expert Opin Ther Targets; 2007 Aug; 11(8):1011-8. PubMed ID: 17665974
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin.
Qin F; Patel R; Yan C; Liu W
Free Radic Biol Med; 2006 Jan; 40(2):236-46. PubMed ID: 16413406
[TBL] [Abstract][Full Text] [Related]
8. Sinomenine Attenuates Angiotensin II-Induced Autophagy via Inhibition of P47-Phox Translocation to the Membrane and Influences Reactive Oxygen Species Generation in Podocytes.
Wang W; Cai J; Tang S; Zhang Y; Gao X; Xie L; Mou Z; Wu Y; Wang L; Zhang J
Kidney Blood Press Res; 2016; 41(2):158-67. PubMed ID: 26919366
[TBL] [Abstract][Full Text] [Related]
9. Aspirin suppresses cardiac fibroblast proliferation and collagen formation through downregulation of angiotensin type 1 receptor transcription.
Wang X; Lu J; Khaidakov M; Mitra S; Ding Z; Raina S; Goyal T; Mehta JL
Toxicol Appl Pharmacol; 2012 Mar; 259(3):346-54. PubMed ID: 22306536
[TBL] [Abstract][Full Text] [Related]
10. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy.
Eid S; Abou-Kheir W; Sabra R; Daoud G; Jaffa A; Ziyadeh FN; Roman L; Eid AA
J Biol Regul Homeost Agents; 2013; 27(3):693-703. PubMed ID: 24152838
[TBL] [Abstract][Full Text] [Related]
11. Role of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An Update.
Wan C; Su H; Zhang C
Oxid Med Cell Longev; 2016; 2016():7813072. PubMed ID: 27597884
[TBL] [Abstract][Full Text] [Related]
12. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
Qin J; Xie YY; Huang L; Yuan QJ; Mei WJ; Yuan XN; Hu GY; Cheng GJ; Tao LJ; Peng ZZ
Nephrology (Carlton); 2013 Oct; 18(10):690-9. PubMed ID: 23841831
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
14. Nox-4 and progressive kidney disease.
Thallas-Bonke V; Jandeleit-Dahm KA; Cooper ME
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):74-80. PubMed ID: 25402870
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
16. NOX in liver fibrosis.
De Minicis S; Brenner DA
Arch Biochem Biophys; 2007 Jun; 462(2):266-72. PubMed ID: 17531188
[TBL] [Abstract][Full Text] [Related]
17. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
19. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy.
Li JM; Shah AM
J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S221-6. PubMed ID: 12874435
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
